 Axcella Health Inc NASDAQ: AXLA is a clinical-stage biotechnology company focused on endogenous metabolic modulators, or EEMs, said Axcella Health CEO Bill Hinshaw Thursday on Benzingas YouTube show Power Hour. Axcella Health has two rapidly progressing Phase II late-stage clinical development programs, he said. 